Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland.
Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070, Basel, Switzerland.
Chemistry. 2020 Jan 27;26(6):1380-1387. doi: 10.1002/chem.201904584. Epub 2020 Jan 21.
The endocannabinoid (eCB) system is implied in various human diseases ranging from central nervous system to autoimmune disorders. Cannabinoid receptor 2 (CB R) is an integral component of the eCB system. Yet, the downstream effects elicited by this G protein-coupled receptor upon binding of endogenous or synthetic ligands are insufficiently understood-likely due to the limited arsenal of reliable biological and chemical tools. Herein, we report the design and synthesis of CB R-selective cannabinoids along with their in vitro pharmacological characterization (binding and functional studies). They combine structural features of HU-308 and AM841 to give chimeric ligands that emerge as potent CB R agonists with high selectivity over the closely related cannabinoid receptor 1 (CB R). The synthesis work includes convenient preparation of substituted resorcinols often found in cannabinoids. The utility of the synthetic cannabinoids in this study is showcased by preparation of the most selective high-affinity fluorescent probe for CB R to date.
内源性大麻素(eCB)系统参与了从中枢神经系统到自身免疫性疾病等多种人类疾病。大麻素受体 2(CB R)是 eCB 系统的一个组成部分。然而,由于可靠的生物学和化学工具的有限储备,这种 G 蛋白偶联受体在结合内源性或合成配体时引发的下游效应还不够了解——这可能是由于缺乏可靠的生物学和化学工具。在此,我们报告了 CB R 选择性大麻素的设计和合成,以及它们的体外药理学特性(结合和功能研究)。它们结合了 HU-308 和 AM841 的结构特征,形成了嵌合配体,这些配体作为强效 CB R 激动剂出现,对密切相关的大麻素受体 1(CB R)具有高选择性。该合成工作包括通常在大麻素中发现的取代间苯二酚的方便制备。本研究中合成大麻素的实用性体现在制备了迄今为止最具选择性的高亲和力荧光探针用于 CB R。